Showing 1 - 5 results of 5 for search 'Azita H. Talasaz', query time: 0.03s Refine Results
  1. 1
    Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence

    Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence by Danesh Soltani, Danesh Soltani, Bayan Azizi, Bayan Azizi, Roja Rahimi, Roja Rahimi, Azita H. Talasaz, Azita H. Talasaz, Hossein Rezaeizadeh, Ali Vasheghani-Farahani, Ali Vasheghani-Farahani

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Novel combined topical gel of lidocaine–verapamil–nitroglycerin can dilate the radial artery and reduce radial pain during trans-radial angioplasty

    Novel combined topical gel of lidocaine–verapamil–nitroglycerin can dilate the radial artery and reduce radial pain during trans-radial angioplasty by Sevda mikailiMirak, Azita H. Talasaz, Yaser Jenab, Alireza Vatanara, Mohsen Amini, Arash Jalali, Azin Gheymati

    Published 2021-02-01
    Get full text
    Article
  3. 3
    Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction

    Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to L... by Michele Golino, Francesco Moroni, Salvatore Carbone, Giuliana Corna, Cory Trankle, Hayley E. Billingsley, Marco G. Del Buono, Azita H. Talasaz, Georgia K. Thomas, Roberto De Ponti, Jeremy Turlington, Roshanak Markley, Ross Arena, Justin M. Canada, Benjamin Van Tassell, Antonio Abbate

    Published 2023-09-01
    Get full text
    Article
  4. 4
    Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study

    Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study by Benjamin Van Tassell, Virginia Mihalick, Georgia Thomas, Amr Marawan, Azita H. Talasaz, Juan Lu, Le Kang, Amy Ladd, Juan Ignacio Damonte, Dave L. Dixon, Roshanak Markley, Jeremy Turlington, Emily Federmann, Marco Giuseppe Del Buono, Giuseppe Biondi-Zoccai, Justin M. Canada, Ross Arena, Antonio Abbate

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra

    Change in Eosinophil Count in Patients with Heart Failure Treated with Anakinra by Michele Golino, Francesco Moroni, Marco Giuseppe Del Buono, Justin M. Canada, Azita H. Talasaz, Sebastian Piñel, James Mbualungu, Alessandra Vecchiè, Ai-Chen (Jane) Ho, Georgia K. Thomas, Salvatore Carbone, Hayley E. Billingsley, Jeremy Turlington, Roshanak Markley, Cory Trankle, Roberto De Ponti, Benjamin Van Tassell, Antonio Abbate

    Published 2023-04-01
    Get full text
    Article

Search Tools: